The weekly litigation news digest is live. Subscribe now

IP Verse

New Process For The Synthesis Of 1-(2-((2,4-Dimethylphenyl)Thio)Phenyl)Piperazine - EP2981520

The patent EP2981520 was granted to LEK Pharmaceuticals DD on Mar 6, 2019. The application was filed on Apr 4, 2014 under application number EP14715016A. The patent is currently recorded with a legal status of "Revoked".

EP2981520

LEK PHARMACEUTICALS DD
Application Number
EP14715016A
Filing Date
Apr 4, 2014
Status
Revoked
Jun 2, 2023
Publication Date
Mar 6, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
HGFDec 6, 2019HGFADMISSIBLE
DIPHARMA FRANCISDec 5, 2019BIANCHETTI & MINOJA WITH TREVISAN & CUONZO IPSADMISSIBLE

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONWO03029232
INTERNATIONAL-SEARCH-REPORTWO03029232
OPPOSITIONEP2981520
OPPOSITIONWO03029232
OTHERUS7144884

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents